⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

LH

Labcorp Holdings Inc.

Healthcare · Diagnostics & Research

321.10USD

-3.7600 (-1.16%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 321.10
P/E26.0
Dvd Ind Yld0.9%
P/B3.03
P/S1.8
Curr EV/T12M EBITDA14.9
Mkt Cap (USD)26.0B
Curr EV (USD)32.7B
2)

Per Share Data

EPS T12M12.08
DPS2.92
Bk Val Per Sh106.39
Rev/Sh174.98
Cash/Sh1.75
Curr Shares Out81.1M
FCF/Sh14.09
3)

Cash Flow Analysis

P/CF15.9
Curr P/FCF22.5
CF/NI1.6
Dvd P/O23.9%
Cash Gen/Cash Reqd2.3
Csh Dvd Cov6.9
CFO/Sales11.4%
Eff Interest Rate4.2%
4)

Growth Potential

Dil EPS 1Y Gr18.3%
Cap 1Y Gr-1.2%
BPS 1Y Gr7.8%
R&D To Sales—
Retention Rate76.1%
Rev 1Y Gr7.2%
FCF 1Y Gr10.0%
Assets 1Y Gr0.1%
5)

Profitability

EBITDA2.2B
EBIT1.5B
Operating Margin10.4%
Pretax Margin—
Net Margin7.0%
ROA5.5%
ROE11.7%
ROC—
Asset Turnover0.78
6)

Structure

Current Ratio1.80
Quick Ratio1.25
Debt/Assets31.6%
Debt/Com Eq68.1%
Net Debt/EBITDA2.61
Tot Debt/Capital40.5%
Gross Margin28.9%
EBIT/Int Exp6.6

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.